CRPC PC346C cell lines (27 sublines made resistant to common antiandrogens) – Bicalutamide A
| Inventor | Institute |
|---|---|
| Wytske van Weerden | Erasmus University Medical Centre |
| SKU: | 161821 |
|---|---|
| Product description: | CRPC PC346C cell lines (27 sublines made resistant to common antiandrogens) – Bicalutamide A |
| Gender: | Male |
| Cat. #: | 161821 |
|---|---|
| Cancer types: | Prostate cancer |
| Research Fields: | Cancer |
| Organism: | Human |
| Tissue: | Transurethral resection of the prostate (TURP) |
| Gender: | Male |
| Primary citation: | Moll et al. 2022. Frontiers in oncology. 12:877613. PMID: 35769712 |
| Format: | Frozen |
|---|---|
| Shipping conditions: | Dry ice |
| Growth medium: | PGM+2C+BIC 1uM |
| Temperature: | 37° C |
| Atmosphere: | 5% CO2 |
| Storage medium: | PGM+20C+7.5% DMSO |
| Biosafety level: | 2 |
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.